BeAble Capital
Edit

BeAble Capital

http://www.beablecapital.com/
Last activity: 10.05.2024
Invests in categories: TechnologySpace3DDesignMaterialsHardwareHumanEngineeringResearchSensors
Independent Venture Capital firm specialized in Indutrial High Technology transfer and Seed and Early stages. Investment on Seed and Early Stage in Industrial High Technologies with the goal to transfer to the society the technologies coming from academic and research institutions, providing support for translating breakthrough discoveries into products thorught start-ups internationally competitive. Focus on Deep Science and Technology Transfer - The process of transforming the results of research and development into marketable products and services through the creation of start-up businesses or spin-out companies. We build close ties with universities, research centers, technology transfer offices, industrial companies to access promising projects. The selection process involves the evaluation of scientific research, intellectual property, competitive technologies both from a scientific and marketing perspective. Dealing with disruptive technologies with with sustainable competitive advantages based on the company’s IP and know-how and high added value. Investment strategy on High Technology (Key Enabling Technologies) - Nanotechnology, Advanced Materials, Photonics, Micro and Nanoelectronic, Industrial Biotechnology and ITC. Expertise on the development on the first phases of industrial start-ups: Proof of Concept, Escalation, Pilot Plant or Prototipe, Flag-Ship, Pre-Industrial phases and launching to the market, , where the companies can be financed further by the normal Venture capital / Private equity investor.
News
38
Portfolio
14
Persons
9
Mentions
36
Location: Spain, Community of Madrid, Madrid
Employees: 1-10
Founded date: 2015
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A; Private Equity

Portfolio 14

Show more

Persons 9

DateFirst NameLast NameTitleLinkedInLocation
-GonzaloSánchez Te...Controller...linkedin.c...-
-AlbertoDíaz Gonzá...Socio fund...linkedin.c...-
-JavierManzano Gó...Responsabl...linkedin.c...-
-MariaGarciaResponsabl...-
-AlmudenaTrigo Lore...Partner / ...linkedin.c...-
-DavidLopez Garc...Cofounder ...linkedin.c...-
-DiegoRuiz Gómez...Analista d...linkedin.c...-
-praveen ku...vuppalacenter hea...linkedin.c...-
-GonzaloNúñez Rey...Financial ...linkedin.c...-

News 38

DateTitleDescription
25.11.2021Science equity: the key to withstanding future crises similar to COVID-19?Within the value chain of unlisted capital, science equity represents an investment category, as does venture capital or private equity, where investments are destined exclusively to companies or projects arising from the scientific field.
25.11.2021Investment and innovation in science # NaciónInnovación240In this program they speak Almudena Trigo, founding partner & Chairwoman BeAble Capital; Irene Zaldívar, CEO of AD Particles; and Elena Rivas, CEO of A4Cell; on investment and innovation in science.
08.07.2021First European Summit of Science Equity: 'Facing Challenges Summit Madrid 2021', sponsored by ICEX-Invest in Spain, with the support of ASCRI, will be held on June 8On June 8, the Facing Challenges Summit Madrid 2021 will be held for the first time, the first summit around Science Equity or technology transfer focused on Deep Science. The summit, which will take place in a hybrid format, will be broadc...
08.07.2021The ‘Science Equity’ is born: a new asset class within the investment landscape that names funds specialized in Technology Transfer in Deep ScienceScience Equity, technology transfer funds in Deep Science, is a new investment category already endorsed by large organizations, such as the European Investment Fund (EIF), and also by the Government of Spain, which supports the celebration...
08.07.2021The biotech startup CellDrive receives 169,250 euros from BeAble CapitalCellDrive produces a new biotin platform that seeks to revolutionize tissue engineering to help transform the future of medicine.
08.07.2021BeAble Capital increases the creation of scientific-based industrial companies in Spain by 10%BeAble Capital, which has 35 million euros in assets under management, has increased the creation of industrial companies emerging from scientific fields in Spain by 10%.
08.07.2021Science equity Facing Challenges Summit Madrid concludesThe summit featured the opening speech of the Minister of Science and Innovation, Pedro Duque and brought together European science equity funds, private investors, large corporations and institutions in Madrid.
27.04.2021BeAble Capital invests 183,400 euros in Glasskin and its disruptive technology applicable in the glass manufacturing sector.This novel technology allows to improve the properties of the glass reducing the environmental impact of the sector.
15.12.2020BeAble Capital invierte 400.000 euros en la nanociencia de Next TipThe Spanish venture capital fund, specialised in scientific projects, BeAble Capital is investing 400,000 Euros in Next Tip, a spin-off of the Centro Superior de Investigaciones Científicas (CSIC) for the design, development, scaling and pr...
27.10.2020BeAble Capital, a leading venture in Science Equity, invests 160,000€ in Porous Inks Technologies (PINKs)This new technology works with materials called MOF 'Metal Organic Frameworks', which could have multiple applications, such as generating drinking water or capturing carbon dioxide to slow down climate change.
Show more

Mentions in press and media 36

DateTitleDescription
10.05.2024BeAble Capital invests €174K in Ecogranular's wastewater treatment techSpanish private equity fund BeAble Capital has invested €174,000 in Ecogranular, a spin-off of the University of Granada, whose technology aims to transfer wastewater treatment, reducing the water footprint and operating expenses and raisin...
16.11.2023Arrays for Cell Nanodevices (A4CELL) cierra una ronda de €3M liderada por Dreavent y en la que participan BeAble Capital y CDTI16/11/2023 Nota de prensa ARRAYS FOR CELL NANODEVICES (A4CELL) CIERRA UNA RONDA DE €3M LIDERADA POR DREAVENT Y EN LA QUE PARTICIPAN BEABLE CAPITAL Y CDTI · A4CELL es una empresa biotecnológica española líder en el análisis de células ind...
31.10.2023BeAble Capital invierte 1 millón de euros en la empresa biotecnológica ALA Diagnostics31/10/2023 Nota de prensa BEABLE CAPITAL INVIERTE 1 MILLÓN DE EUROS EN LA STARTUP BIOTECNOLÓGICA ALA DIAGNOSTICS ALA Diagnostics es una empresa desarrolladora y comercializadora de Kits de Diagnóstico in vitro Madrid, 31 de octubre de 2...
27.10.2023A4cell, participada por BeAble Capital, anuncia una inversión de €3 millones para revolucionar el análisis de células individuales vivas27/10/2023 Nota de prensa A4CELL, PARTICIPADA POR BEABLE CAPITAL, ANUNCIA UNA INVERSIÓN DE €3 MILLONES PARA REVOLUCIONAR EL ANÁLISIS DE CÉLULAS INDIVIDUALES VIVAS A4cell, participada por BeAble Capital, ha anunciado recientemente un hito...
06.07.2023BeAble Capital invierte 1 millón de euros en SafeLoc Systems06/07/2023 Nota de prensa BEABLE CAPITAL INVIERTE 1 MILLÓN DE EUROS EN SAFELOC SYSTEMS El pasado mes de mayo BeAble Capital, la entidad de capital riesgo (Venture Capital) especializada en Science Equity – transferencia tecnológica en De...
30.05.2023INBENTUS Medical Technology cierra una ronda de más €2M liderada por BeAble. Participa Murcia Emprende30/05/2023 Nota de prensa INBENTUS MEDICAL TECHNOLOGY CIERRA UNA RONDA DE MÁS €2M LIDERADA POR BEABLE. PARTICIPA MURCIA EMPRENDE INBENTUS Medical Technology, una empresa pionera en el ámbito de la tecnología médica, ha anunciado una ampl...
19.05.2023BeAble Innvierte Science Equity Fund FCRE, el nuevo fondo de BeAble que contará con 50M€BeAble Capital, gestora de fondos de capital privado especializada en Science Equity - transferencia tecnológica en Deep Science - empezó su andadura con un fondo bajo gestión de 35 millones de euros, al que hay que sumar ahora un nuevo fon...
18.05.2023BeAble Innvierte Science Equity Fund, nuevo fondo de €50M para BeAble Capital18/05/2023 Nota de prensa BEABLE INNVIERTE SCIENCE EQUITY FUND, NUEVO FONDO DE €50M PARA BEABLE CAPITAL BeAble Capital, gestora de fondos de capital privado especializada en Science Equity – transferencia tecnológica en Deep Science – em...
15.06.2022BeAble Capital invierte €450.000 en la tecnología disruptiva de Next-Gen Leather15/06/2022 Nota de prensa BEABLE CAPITAL INVIERTE €450.000 EN LA TECNOLOGÍA DISRUPTIVA DE NEXT-GEN LEATHER. Bioingeniería para producir cuero realmente sostenible. Next-Gen Leather desarrolla cuero cultivado con materiales biológicos y ...
18.03.2022Molecular Gate, spin-off del ICMAB-CSIC y BeAble, ofrece una transformadora tecnología que asegura la autenticidad de los productos farmacéuticos18/03/2022 Nota de prensa MOLECULAR GATE, S.L, NUEVA SPIN OFF DEL ICMAB-CSIC Y BEABLE CAPITAL, OFRECE UNA TRANSFORMADORA TECNOLOGÍA QUE ASEGURA LA AUTENTICIDAD DE LOS PRODUCTOS FARMACEUTICOS. ¿Cómo podemos asegurar que los medicamentos q...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In